CHARACTERIZATION OF CAMPTOTHECIN-RESISTANT CHINESE-HAMSTER LUNG-CELLS

被引:81
作者
CHANG, JY
DETHLEFSEN, LA
BARLEY, LR
ZHOU, BS
CHENG, YC
机构
[1] YALE UNIV,SCH MED,DEPT PHARMACOL,333 CEDAR ST,NEW HAVEN,CT 06510
[2] UNIV UTAH,HLTH SCI CTR,DEPT RADIOL,SALT LAKE CITY,UT 84132
关键词
D O I
10.1016/0006-2952(92)90325-D
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Three camptothecin-resistant sublines (V79r, IRS-1r and IRS-2r) of V79 cells and their irradiation-sensitive mutants, IRS-1 and IRS-2, were developed by stepwise, continuous exposure to camptothecin (CPT). The degree of resistance varied among these cells. Based on the biochemical characterizations of these resistant cell lines, the mechanisms which could be responsible for the resistance of CPT were proposed to be: (a) a decrease in the intracellular accumulation of CPT with or without alteration of DNA topoisomerase I, (b) a decrease in the amount of DNA topoisomerase I, or (c) a decrease in the sensitivity of DNA topoisomerase I to CPT. The resistant cells which exhibited down-regulation of DNA topoisomerase I were collaterally sensitive to etoposide (VP-16) and its analogue, 4'-demethy-4-beta-(4"-fluoroanilino)-4-desoxypodophyll?? otoxin, despite the fact that there were equal amounts of DNA topoisomerase II in the parental and in the resistant cell lines. Alternating the usage of CPT and VP-16 for the treatment of cancer is indicated.
引用
收藏
页码:2443 / 2452
页数:10
相关论文
共 45 条
[41]   DNA-BREAK REPAIR, RADIORESISTANCE OF DNA-SYNTHESIS, AND CAMPTOTHECIN SENSITIVITY IN THE RADIATION-SENSITIVE IRS MUTANTS - COMPARISONS TO ATAXIA-TELANGIECTASIA CELLS [J].
THACKER, J ;
GANESH, AN .
MUTATION RESEARCH, 1990, 235 (02) :49-58
[42]  
TSURUO T, 1988, CANCER CHEMOTH PHARM, V21, P71
[43]   PLANT ANTITUMOR AGENTS .I. ISOLATION AND STRUCTURE OF CAMPTOTHECIN A NOVEL ALKALOIDAL LEUKEMIA AND TUMOR INHIBITOR FROM CAMPTOTHECA ACUMINATA [J].
WALL, ME ;
WANI, MC ;
COOK, CE ;
PALMER, KH ;
MCPHAIL, AT ;
SIM, GA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1966, 88 (16) :3888-3890
[44]  
YALOWICH JC, 1985, CANCER RES, V45, P1651
[45]  
ZHANG H, 1990, CANCER CELL-MON REV, V2, P23